Drugs / Inactivated Split Influenza Vaccine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05126979 | Mar → Apr 2016 | influenza | St. Petersburg Research Institute of Vaccines and Sera | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00945841 | Jun 2009 | influenza | Novartis | Completed | No outcome recorded |
| Phase 3 | NCT00354016 | Jul 2006 → ? | influenza | Novartis | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05089123 Comparator | Mar → May 2020 | influenza | St. Petersburg Research Institute of Vaccines and Sera | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Split Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05089123 ↗ |
| Modality | Vaccine | “influenza vaccines” NCT00354016 ↗ |
| Route | Intramuscular | “solution for intramuscular injection, 0.5 ml” NCT05089123 ↗ |